Cephalexin
To view the entire topic, please log in or purchase a subscription.
Official website of the Johns Hopkins Antibiotic (ABX), HIV, Diabetes, and Psychiatry Guides, powered by Unbound Medicine. Johns Hopkins Guide App for iOS, iPhone, iPad, and Android included. Explore these free sample topics:
-- The first section of this topic is shown below --
INDICATIONS
FDA
- Respiratory tract infections S. pneumoniae and S. pyogenes
- Author’s comment: generally not recommended, certainly empirically.
- Otitis media caused by S. pneumoniae, H. influenzae, S. aureus (MSSA), S. pyogenes, and M. catarrhalis
- Skin and skin-structure infections caused by S. pyogenes and S. aureus (MSSA)
- Osteomyelitis: MSSA and/or P. mirabilis
- Author’s comment: not a first-line agent.
- Urinary tract infections including acute prostatitis caused by E. coli, P. mirabilis, and K. pneumoniae
- Author’s comment: not a first-line agent
NON-FDA APPROVED USES
-- To view the remaining sections of this topic, please log in or purchase a subscription --
INDICATIONS
FDA
- Respiratory tract infections S. pneumoniae and S. pyogenes
- Author’s comment: generally not recommended, certainly empirically.
- Otitis media caused by S. pneumoniae, H. influenzae, S. aureus (MSSA), S. pyogenes, and M. catarrhalis
- Skin and skin-structure infections caused by S. pyogenes and S. aureus (MSSA)
- Osteomyelitis: MSSA and/or P. mirabilis
- Author’s comment: not a first-line agent.
- Urinary tract infections including acute prostatitis caused by E. coli, P. mirabilis, and K. pneumoniae
- Author’s comment: not a first-line agent
NON-FDA APPROVED USES
There's more to see -- the rest of this entry is available only to subscribers.